Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the International AIDS Society 2010-11, Vol.13 (S4), p.O51-O51
Hauptverfasser: Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait‐Khaled, M, Min, S, Yeo, JM
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Antiviral agents
Disease susceptibility
Dosage and administration
HIV infection
HIV testing
Human immunodeficiency virus
Integrase inhibitors
Oral Presentation
Prevention
Risk factors
Testing
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
ISSN:1758-2652
1758-2652
DOI:10.1186/1758-2652-13-S4-O51